Oxaliplatin use in pressurized intraperitoneal aerosole chemotherapy(PIPAC) is safe and well tolerated: a multicenter study

Volume: 45, Issue: 2, Pages: e60 - e60
Published: Feb 1, 2019
Abstract
Background: Pressurized intraperitoneal chemotherapy(PIPAC) is a relatively new drug delivery method used in patients with peritoneal metastases of primary or secondary origin. Oxaliplatin was reluctantly used in PIPAC due to feared toxicity, especially abdominal pain. The objective of this multiinstitutional study is to assess oxaliplatin-associated tolerance profile on a large cohort of...
Paper Details
Title
Oxaliplatin use in pressurized intraperitoneal aerosole chemotherapy(PIPAC) is safe and well tolerated: a multicenter study
Published Date
Feb 1, 2019
Volume
45
Issue
2
Pages
e60 - e60
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.